People with chronic insomnia are also at a higher risk of developing sleep-related disorders ... The correlation of anxiety and depression with obstructive sleep apnea syndrome. J Res Med Sci. 2014;19 ...
Oxygen can be used to treat people with chronic obstructive pulmonary disease (COPD), such as emphysema. But the use of oxygen to treat OSA without CPAP or bilevel therapy can actually cause breathing ...
Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...
The aura6000 is an implantable hypoglossal neurostimulator intended to treat adult patients with moderate to severe obstructive sleep apnea (OSA). In the OSPREY study, apnea-hypopnea index (AHI) and ...
Vivos' cost-cutting initiatives also led to a $1 million or 27% year-over-year reduction in operating loss, versus the third quarter of 2023. For the nine months ended September 30, 2024 operating ...
The aura6000 is an implantable hypoglossal neurostimulator intended to treat adult patients with moderate to severe obstructive sleep apnea. In the OSPREY study, apnea-hypopnea index and oxygen ...
Strategically, Vivos achieved notable milestones including receiving FDA clearance for its devices to treat moderate to severe obstructive sleep apnea in children, and the introduction of new medical ...
Obstructive Sleep Apnea May Increase Risk of Abdominal Aortic Aneurysms Sep. 25, 2024 — Intermittent hypoxia caused by obstructive sleep apnea increased the susceptibility of mice to develop ...